AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2021
Aug 6, 2021
35475_dirs_2021-08-06_dc894fc5-501b-4e43-8bed-c82b85f5242b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2021-08-03
Reporting Person: O'CALLAGHAN BRIAN (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.80 | 2028-11-25 | Common Stock (20926) | Direct |
Footnotes
F1: Options to buy 19,190 shares are fully vested and exercisable. The remaining options shall vest at the rate of an additional 582 shares on the first calendar day of each month commencing September 1, 2021, such that all Options shall be fully vested on November 1, 2021.
More from Indaptus Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12
Director's Dealing
2026
Jan 23